Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial

Dora Koller; Susana Almenara; Gina Mejía; Miriam Saiz-Rodríguez; Pablo Zubiaur; Manuel Román; Dolores Ochoa; Aneta Wojnicz; Samuel Martín; Daniel Romero-Palacián; Marcos Navares-Gómez; Francisco Abad-Santos

doi:10.1101/2020.08.03.20167502

Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial

View ORCID ProfileDora Koller, View ORCID ProfileSusana Almenara, View ORCID ProfileGina Mejía, View ORCID ProfileMiriam Saiz-Rodríguez, View ORCID ProfilePablo Zubiaur, Manuel Román, Dolores Ochoa, Aneta Wojnicz, Samuel Martín, Daniel Romero-Palacián, View ORCID ProfileMarcos Navares-Gómez, View ORCID ProfileFrancisco Abad-Santos

doi: https://doi.org/10.1101/2020.08.03.20167502

Dora Koller

1Clinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto Teófilo Hernando, School of Medicine, Universidad Autónoma de Madrid, Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain

MSc

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Dora Koller

Susana Almenara

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Susana Almenara

Gina Mejía

2UICEC Hospital Universitario de La Princesa, Platform SCReN (Spanish Clinical Research Network), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Gina Mejía

Miriam Saiz-Rodríguez

3Research Unit, Fundación Burgos por la Investigación de la Salud, Hospital Universitario de Burgos, Burgos, Spain

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Miriam Saiz-Rodríguez

Pablo Zubiaur

MPharm

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Pablo Zubiaur

Manuel Román

2UICEC Hospital Universitario de La Princesa, Platform SCReN (Spanish Clinical Research Network), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain

MLT

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dolores Ochoa

2UICEC Hospital Universitario de La Princesa, Platform SCReN (Spanish Clinical Research Network), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain

MD, PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Aneta Wojnicz

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Samuel Martín

2UICEC Hospital Universitario de La Princesa, Platform SCReN (Spanish Clinical Research Network), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel Romero-Palacián

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marcos Navares-Gómez

MLT

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Marcos Navares-Gómez

Francisco Abad-Santos

2UICEC Hospital Universitario de La Princesa, Platform SCReN (Spanish Clinical Research Network), Instituto de Investigación Sanitaria La Princesa (IP), Madrid, Spain

MD, PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Francisco Abad-Santos
For correspondence: francisco.abad{at}salud.madrid.org

Abstract
Full Text
Info/History
Metrics
Data/Code
Preview PDF

Data Availability

The details about the study are available on the webpage of the Spanish Agency of Medicines and Health Products.

https://reec.aemps.es/reec/public/detail.html

View the discussion thread.

PreviousNext

Posted August 07, 2020.

Download PDF

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial

Dora Koller, Susana Almenara, Gina Mejía, Miriam Saiz-Rodríguez, Pablo Zubiaur, Manuel Román, Dolores Ochoa, Aneta Wojnicz, Samuel Martín, Daniel Romero-Palacián, Marcos Navares-Gómez, Francisco Abad-Santos

medRxiv 2020.08.03.20167502; doi: https://doi.org/10.1101/2020.08.03.20167502

Share This Article: